Rankings
▼
Calendar
DFTX Q2 2018 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q2 2018 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
-$6,960
Operating Income
-$472,445
Net Income
-$471,489
EPS (Diluted)
$-1.51
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$136,270
Free Cash Flow
-$136,270
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$3M
Total Liabilities
$28,274
Stockholders' Equity
$3M
Cash & Equivalents
$106,887
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$6,960
$0
—
Operating Income
-$472,445
-$413,615
-14.2%
Net Income
-$471,489
-$410,931
-14.7%
← FY 2018
All Quarters
Q3 2018 →